IRD vs XLP
Opus Genetics, Inc. (IRD) versus XLP (XLP) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
XLP (XLP) common stock.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
XLP does not have a complete income-statement cache yet.
IRD currently screens at market cap $35.7M. XLP currently screens at market cap $0.
Not investment advice. Open the IRD and XLP stock pages for the full models.
Not investment advice.